He aha te tikanga o te "Maama"?
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Kuri Cerebellar Degeneration-Myositis Complex (CDMC)
Cerebellar Degeneration-Myositis Complex (CDMC) is a genetic condition affecting dogs, leading to severe neurological and muscular issues. A DNA test for CDMC can help identify carriers and affected dogs, allowing for informed breeding decisions. Early detection through genetic testing is crucial, as it enables proactive management and care for affected pets. Owners should consult with veterinarians to understand the implications of a positive CDMC test result. By prioritizing genetic health, dog breeders can contribute to the overall wellness of future generations. Ensure your dog's health and well-being by considering a DNA test for CDMC today. Stay informed and take action to protect your furry friends from hereditary conditions.
Whakapoto: CDMC
Irakētanga kua tātarihia: SLC25A12 c.1337C>T
Tukunga iho: Autosomal Recessive
Acronym
CDMC
Te auau kua tirohia
Te taumahatanga haumanu
Te whakarōpūtanga haumanu
Nga mate neuromuscular
Te whakarerekētanga kua tātarihia
SLC25A12 c.1337C>T
p.(P446L)
p.(P446L)
Te tikanga tuku iho
Autosomal Recessive
Whakarāpopototanga whakamātautau:
Cerebellar Degeneration-Myositis Complex (CDMC) is a genetic condition affecting certain dog breeds, leading to neurological and muscular issues. A DNA test can identify carriers and affected individuals, helping breeders make informed decisions to reduce the prevalence of this complex disorder. Symptoms may include coordination problems and muscle weakness, which can significantly impact a dog's quality of life. Early detection through genetic testing allows for better management and care. Responsible breeding practices are essential in minimizing the risk of CDMC in future generations.
Kei te waatea mai i te kete: Basic
Kua whakauruhia tenei whakamatautau DNA mai i ta maatau kete Basic — he waahanga ano hoki o nga kete Basic, Standard, Advanced, Complete.
Tirohia nga Puka Whakamatau DNA →Kōwhirihia te mōkihi e pai ana ki to momo whakatipu, rautaki hauora ranei o au kararehe.
Understanding Cerebellar Degeneration-Myositis Complex (CDMC)
Cerebellar Degeneration-Myositis Complex (CDMC) is a serious neurological and muscular condition that affects dogs. This complex disease is characterized by two main components: cerebellar degeneration, which impacts the brain's ability to coordinate movement, and myositis, an inflammatory condition of the muscles. Together, these issues can lead to a range of debilitating symptoms that impact a dog's quality of life.
Symptoms and Clinical Manifestations
Dogs suffering from CDMC often exhibit a variety of symptoms that may vary in severity. Common clinical signs include ataxia, which is a lack of coordination and balance, leading to difficulty in walking and performing routine activities. Affected dogs may also display tremors, muscle weakness, and a noticeable decline in muscle mass due to myositis. In some cases, the condition may cause behavioral changes, including lethargy or reluctance to engage in physical activities.
Pathophysiology of CDMC
The pathophysiology of CDMC involves a combination of neurological and immunological factors. The cerebellum, responsible for coordination and balance, suffers from degeneration, while the immune system mistakenly targets muscle fibers, leading to inflammation. This dual impact results in the clinical signs observed in affected dogs. Research into the underlying genetic and environmental factors contributing to CDMC is ongoing, with a focus on understanding how these elements interact to trigger the disease.
Te Hiranga o te Whakamatau DNA
DNA testing plays a crucial role in identifying and diagnosing CDMC in dogs. By analyzing specific genetic markers associated with the condition, veterinary professionals can determine the likelihood of a dog carrying the genes responsible for CDMC. Early detection through DNA testing can provide pet owners with valuable information regarding their dog's health and guide them in making informed decisions about management and care.
Nga Kōwhiringa Whakahaere me te Maimoatanga
Currently, there is no cure for CDMC; however, various management strategies can help improve a dog's quality of life. Supportive care, including physical therapy and nutritional support, can play a significant role in maintaining muscle strength and mobility. In some cases, medications to reduce inflammation and manage symptoms may be prescribed. Regular veterinary check-ups are essential for monitoring the condition and adjusting treatment plans as needed.
Whakamutunga
Cerebellar Degeneration-Myositis Complex (CDMC) is a complex and challenging condition that requires careful management and support. Understanding the nature of this disease, its symptoms, and potential treatment options is critical for pet owners. DNA testing serves as a valuable tool in the early detection and management of CDMC, enabling better health outcomes for affected dogs.
He momo kua tohua mo te whakamatautau: Cerebellar Degeneration-Myositis Complex (CDMC)
- Nova Scotia Duck Tolling Retriever
🧬 Interpretation of genotypes CDMC
momoira
Tūnga
🟡 N/N
Kaikawe kore - Karekau he Morearea
🟡 N/CDMC
Kaikawe - Karekau he morearea
❌ CDMC/CDMC
Kua Paa - I Te Morearea
FAQ: te mohio ki te whakamaoritanga
He taumaha te "Kaikawe"?
Kao. He hauora te kararehe engari ka taea e ia te tuku i te huringa ki tona uri.
He aha mena ka "Paea" tetahi kararehe?
E rua nga kape whakarereke. Ko nga tohu haumanu kei te tumanakohia te mate. Kaua e whakatipuria.
He aha nga rereketanga i waenga i te tane / wahine?
Ko etahi o nga mate he hononga-a-ira, no reira ka rereke o raatau korero i runga i te ira kararehe.
Matapaea te uri
N/N (kaikawe-kore)
N/CDMC (Kaikawe)
CDMC/CDMC (Ka pangia)
FAQ Whakamātautau DNA
He aha ta tenei whakamatautau DNA ka kitea?
This DNA test detects the mutation associated with Cerebellar Degeneration-Myositis Complex (CDMC) in order to identify clear, carrier, or at-risk animals.
He aha te whakamatautau i te kararehe whakatipu?
Ko te whakamatautau DNA ka awhina i nga kaiwhakawhanake ki te whakamahere i nga hononga haumaru ake me te whakaiti i te tupono ki te tuku i te huringa ki nga uri.
He aha te tikanga tuku iho o tenei whakamatautau?
Ko te tikanga tuku iho mo tenei whakamatautau ko Autosomal Recessive.
Ko tehea whakarerekētanga ka tātarihia i roto i tenei whakamatautau?
This test analyses the mutation SLC25A12 c.1337C>T.
Ko te kararehe kawe kawe ka mate?
Ehara i te mea. Ko te whakamaoritanga ka whakawhirinaki ki te tauira tuku iho me te momo momo ira ka puta.
Tohutoro
Christen Matthias, Rupp Stefan, Van Soens Iris, Bhatti Sofie F M, Matiasek Kaspar, von Klopmann Thilo, Jagannathan Vidhya, Madden Indiana, Batcher Kevin, Bannasch Danika, Leeb Tosso. SLC25A12 Missense Variant in Nova Scotia Duck Tolling Retrievers Affected by Cerebellar Degeneration-Myositis Complex (CDMC). Genes (Basel). 2022 Jul 9;13(7):1223. doi: 10.3390/genes13071223.